230 related articles for article (PubMed ID: 26858195)
1. Amino Acid Metabolism is Altered in Adolescents with Nonalcoholic Fatty Liver Disease-An Untargeted, High Resolution Metabolomics Study.
Jin R; Banton S; Tran VT; Konomi JV; Li S; Jones DP; Vos MB
J Pediatr; 2016 May; 172():14-19.e5. PubMed ID: 26858195
[TBL] [Abstract][Full Text] [Related]
2. Liver fat deposition and mitochondrial dysfunction in morbid obesity: An approach combining metabolomics with liver imaging and histology.
Calvo N; Beltrán-Debón R; Rodríguez-Gallego E; Hernández-Aguilera A; Guirro M; Mariné-Casadó R; Millá L; Alegret JM; Sabench F; del Castillo D; Vinaixa M; Rodríguez MÀ; Correig X; García-Álvarez R; Menendez JA; Camps J; Joven J
World J Gastroenterol; 2015 Jun; 21(24):7529-44. PubMed ID: 26140000
[TBL] [Abstract][Full Text] [Related]
3. Mass-Spectrometry-Based Serum Metabolomics of a C57BL/6J Mouse Model of High-Fat-Diet-Induced Non-alcoholic Fatty Liver Disease Development.
Lai YS; Chen WC; Kuo TC; Ho CT; Kuo CH; Tseng YJ; Lu KH; Lin SH; Panyod S; Sheen LY
J Agric Food Chem; 2015 Sep; 63(35):7873-84. PubMed ID: 26262841
[TBL] [Abstract][Full Text] [Related]
4. Clinical and metabolic characterization of obese subjects without non-alcoholic fatty liver: A targeted metabolomics approach.
Feldman A; Eder SK; Felder TK; Paulweber B; Zandanell S; Stechemesser L; Schranz M; Strebinger G; Huber-Schönauer U; Niederseer D; Patsch W; Weghuber D; Tevini J; Datz C; Aigner E
Diabetes Metab; 2019 Apr; 45(2):132-139. PubMed ID: 30266576
[TBL] [Abstract][Full Text] [Related]
5. Urinary metabolomics analysis identifies key biomarkers of different stages of nonalcoholic fatty liver disease.
Dong S; Zhan ZY; Cao HY; Wu C; Bian YQ; Li JY; Cheng GH; Liu P; Sun MY
World J Gastroenterol; 2017 Apr; 23(15):2771-2784. PubMed ID: 28487615
[TBL] [Abstract][Full Text] [Related]
6. A metabolomics approach to the validation of predictive metabolites and phenotypic expression in non-alcoholic fatty liver disease.
Ganesan R; Gupta H; Jeong JJ; Sharma SP; Won SM; Oh KK; Yoon SJ; Kim DJ; Suk KT
Life Sci; 2023 Jun; 322():121626. PubMed ID: 37003543
[TBL] [Abstract][Full Text] [Related]
7. Urinary metabolic phenotyping of mucopolysaccharidosis type I combining untargeted and targeted strategies with data modeling.
Tebani A; Schmitz-Afonso I; Abily-Donval L; Héron B; Piraud M; Ausseil J; Brassier A; De Lonlay P; Zerimech F; Vaz FM; Gonzalez BJ; Marret S; Afonso C; Bekri S
Clin Chim Acta; 2017 Dec; 475():7-14. PubMed ID: 28982054
[TBL] [Abstract][Full Text] [Related]
8. Cross-talk between branched-chain amino acids and hepatic mitochondria is compromised in nonalcoholic fatty liver disease.
Sunny NE; Kalavalapalli S; Bril F; Garrett TJ; Nautiyal M; Mathew JT; Williams CM; Cusi K
Am J Physiol Endocrinol Metab; 2015 Aug; 309(4):E311-9. PubMed ID: 26058864
[TBL] [Abstract][Full Text] [Related]
9. Hepatic Steatosis Is Associated With Adverse Molecular Signatures in Subjects Without Diabetes.
Pietzner M; Budde K; Homuth G; Kastenmüller G; Henning AK; Artati A; Krumsiek J; Völzke H; Adamski J; Lerch MM; Kühn JP; Nauck M; Friedrich N
J Clin Endocrinol Metab; 2018 Oct; 103(10):3856-3868. PubMed ID: 30060179
[TBL] [Abstract][Full Text] [Related]
10. Increased circulating zonulin in children with biopsy-proven nonalcoholic fatty liver disease.
Pacifico L; Bonci E; Marandola L; Romaggioli S; Bascetta S; Chiesa C
World J Gastroenterol; 2014 Dec; 20(45):17107-14. PubMed ID: 25493023
[TBL] [Abstract][Full Text] [Related]
11. A Branched-Chain Amino Acid-Related Metabolic Signature Characterizes Obese Adolescents with Non-Alcoholic Fatty Liver Disease.
Goffredo M; Santoro N; Tricò D; Giannini C; D'Adamo E; Zhao H; Peng G; Yu X; Lam TT; Pierpont B; Caprio S; Herzog RI
Nutrients; 2017 Jun; 9(7):. PubMed ID: 28640216
[TBL] [Abstract][Full Text] [Related]
12. Mass spectrometry-based untargeted metabolomics study of non-obese individuals with non-alcoholic fatty liver disease.
Demirel M; Köktaşoğlu F; Özkan E; Dulun Ağaç H; Gül AZ; Sharifov R; Sarıkaya U; Başaranoğlu M; Selek Ş
Scand J Gastroenterol; 2023; 58(11):1344-1350. PubMed ID: 37337892
[TBL] [Abstract][Full Text] [Related]
13. Perfluoroalkyl substances and severity of nonalcoholic fatty liver in Children: An untargeted metabolomics approach.
Jin R; McConnell R; Catherine C; Xu S; Walker DI; Stratakis N; Jones DP; Miller GW; Peng C; Conti DV; Vos MB; Chatzi L
Environ Int; 2020 Jan; 134():105220. PubMed ID: 31744629
[TBL] [Abstract][Full Text] [Related]
14. Metabolomic Salivary Signature of Pediatric Obesity Related Liver Disease and Metabolic Syndrome.
Troisi J; Belmonte F; Bisogno A; Pierri L; Colucci A; Scala G; Cavallo P; Mandato C; Di Nuzzi A; Di Michele L; Delli Bovi AP; Guercio Nuzio S; Vajro P
Nutrients; 2019 Jan; 11(2):. PubMed ID: 30691143
[TBL] [Abstract][Full Text] [Related]
15. Adipose Tissue Dysfunction and Altered Systemic Amino Acid Metabolism Are Associated with Non-Alcoholic Fatty Liver Disease.
Cheng S; Wiklund P; Autio R; Borra R; Ojanen X; Xu L; Törmäkangas T; Alen M
PLoS One; 2015; 10(10):e0138889. PubMed ID: 26439744
[TBL] [Abstract][Full Text] [Related]
16. Untargeted metabolomics characteristics of nonobese nonalcoholic fatty liver disease induced by high-temperature-processed feed in Sprague-Dawley rats.
Xue LJ; Han JQ; Zhou YC; Peng HY; Yin TF; Li KM; Yao SK
World J Gastroenterol; 2020 Dec; 26(46):7299-7311. PubMed ID: 33362385
[TBL] [Abstract][Full Text] [Related]
17. Application of Stable Isotope Labels for Metabolomics in Studies in Fatty Liver Disease.
Puchalska P; Crawford PA
Methods Mol Biol; 2019; 1996():259-272. PubMed ID: 31127561
[TBL] [Abstract][Full Text] [Related]
18. Serum untargeted metabolomics delineates the metabolic status in different subtypes of non-alcoholic fatty liver disease.
Liu L; Zhao J; Zhang R; Wang X; Wang Y; Chen Y; Feng R
J Pharm Biomed Anal; 2021 Jun; 200():114058. PubMed ID: 33865049
[TBL] [Abstract][Full Text] [Related]
19. Plasma metabolomic profile in nonalcoholic fatty liver disease.
Kalhan SC; Guo L; Edmison J; Dasarathy S; McCullough AJ; Hanson RW; Milburn M
Metabolism; 2011 Mar; 60(3):404-13. PubMed ID: 20423748
[TBL] [Abstract][Full Text] [Related]
20. Metabolomics profiling of steatosis progression in HepaRG
Cuykx M; Claes L; Rodrigues RM; Vanhaecke T; Covaci A
Toxicol Lett; 2018 Apr; 286():22-30. PubMed ID: 29355688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
